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       Ixeris  sonchifolia  Hance,  a  normal  perennial  herb,  has  effects  on 
appendicitis,  headache,  menstruation,  blood  circulation,  blood  stasis,  pain, 
fibrinolytic enzymes, thrombus formation, coronary artery, myocardial infarct 
size, PGI2, ET, TXA2, TNF-,αIL-6 and IL-8, etc . However, there was no full 
coverage  about  the  molecular  basis  and  gene  targets  of  Ixeris  sonchifolia 
injection.  PubChem  Database  and  DAVID  Database  had  been  used 
conjunctively to detect the gene IDs, gene targets and their functions. There 
were 3008 genes found in the final results, 16 kinds of definite functions had 
been detected, 9 of which had been proved and the effects were focused on the 
psychological,  immune,  neurological,  metabolic,  cardiovascular  and  cancer 
functions. Ixeris sonchifolia had a wide effects on various symptoms, which 
had  been  reported  by  previous  experiments  and  verified  by  this  research; 
however  its  influences  on  aging,  chemdependency,  developmental, 
normalvariation,  reproduction,  pharmacogenomic  and  psychologic  functions 
should be confirmed in the future experiments.  
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INTRODUCTION 
Ixeris sonchifolia Hance, a member of the Compositae Family, is widely distributed in the 
northeastern place of China, is a small and bitter perennial herb (YAOCHUN et al., 2009). In 
China, as a kind of well-known folk medicine, Ixeris sonchifolia has also been used for many 76                                                                                                                 GENETIKA, Vol. 46, No.1, 75-94, 2014 
years to cure appendicitis, reduce headache, normalize menstruation, invigorate blood circulation 
and eliminate blood stasis in order to relieve pain (HE et al., 2006; FENG et al., 2001). More 
recently,  raw  extract  of  Ixeris  sonchifolia  has  been  made  into  an  injectable  formulation, 
according to the reports, which has biological activities in several aspects such as inhibition of 
platelet aggregation, relaxation of vascular smooth muscle, enhancement of cerebral blood flow, 
improvement of the activities of fibrinolytic enzymes and inhibition of thrombus formation (MAO 
and JING, 2012). A clinical observation and an animal study have confirmed that the injection is 
able  to  expand  coronary  artery,  increase  flow  of  blood,  reduce  cardiac  load  and  decrease 
myocardial infarct size (ZHAOAN and SHOUYUAN, 2005; WANG et al., 2006). The formulation has 
also been found in a study to exhibit therapeutic efficiency in restoring stroke patients’ neural 
functions and recovery of daily vasomotor activities (YI et al., 2005). 
Presently, targets related to the mechanism of Ixeris sonchifolia injection, which has been 
proven by several researches, include prostaglandin I2 (PGI2), endothelin (ET), thromboxane A2 
(TXA2), tumor necrosis Factor- α (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8), and protein 
Bcl-2/Bax (ZHAO-LIANG et al., 2013; LIFANG and MEIJIAN, 2013; WANG et al., 2013). 
However, based on the review of above experiments, there was no full coverage about the 
molecular  basis  and  gene  targets  of  Ixeris  sonchifolia  injection.  Therefore,  particularly  it  is 
important to conduct research of Ixeris sonchifolia injection’s pharmaceutical effect mechanism, 
material basis on molecular level and gene targets. 
Currently,  with  the  development  of  Public  Databases  and  Networked  Pharmacology 
Method, according to the information integration among various databases, the interdisciplinary 
research  has  become  possible,  which  is  able  to  basically  identify  the  indexes  before  the 
experiments, enhance the accuracy and reduce the repeated frequency, and at the same time, the 
research can be finished on the level of molecular and gene targets (DI et al., 2013). 
So the author had conducted the gene targets of Ixeris sonchifolia Injection based on the 
method of information integration among various databases in this research, not only to verify 
the previous experiments but also to give advice to the following designs.  
 
MATERIALS AND METHODS 
Data sources 
The data sources used were PubChem Database and DAVID Database. 
PubChem Database 
PubChem  (http://pubchem.ncbi.nlm.nih.gov),  whose  mission  is  to  provide  intuitive  data 
analysis tools, and to deliver free and easy access to all deposited data, is a public repository for 
biological activity data of small molecules and RNAi reagents. The PubChem BioAssay database 
currently contains 500 000 descriptions of assay protocols, covering 5000 protein targets, 30000 
gene targets and providing over 130 million bioactivity outcomes. Bioassay description and data 
can be searched, reviewed and downloaded on the PubChem information platform by users. And 
it also enables researchers to collect, compare and analyze biological test results through web-
based and programmatic tools (WANG et al., 2009). 
DAVID Database 
All  tools  in  the  DAVID  Bioinformatics  Resources  (http://david.niaid.nih.gov)  aim  to 
provide functional interpretation of large lists of genes derived from genomic studies. DAVID 
Knowledgebase and five integrated, web-based functional annotation tool suites are consisted in W. JIN et al: DATEBASE, Ixeris sonchifolia , GENE TARGETS                                                                     77 
the newly updated DAVID Bioinformatics Resources. The expanded DAVID Knowledgebase 
now integrates almost all major and well-known public bioinformatics resources centralized by 
the DAVID Gene Concept, a single-linkage method to agglomerate tens of millions of diverse 
gene/protein identifiers and annotation terms from a variety of public bioinformatics databases. 
For any uploaded gene list, the DAVID Resources now provides not only the typical gene-term 
enrichment analysis, but also new tools and functions that allow users to condense large gene 
lists into gene functional groups, convert between gene/protein identifiers, visualize many-genes-
to-many-terms relationships, cluster redundant and heterogeneous terms into groups, search for 
interesting and related genes or terms, dynamically view genes from their lists on bio-pathways 
and more. With DAVID, investigators gain more power to interpret the biological mechanisms 
associated with large gene lists. (SHERMAN et al., 2007). 
 
Effective Constituents of Ixeris sonchifolia Injection 
According to previous experiments, the effective constituents of Ixeris sonchifolia injection 
basically  include  chicoric  acid;  uridine;  guanosine;  adenosine;  1-  caffeoylquinic  acid;  3,4-
dihydroxy-caftaric  acid;  3-  caffeoylquinic  acid;  caffeic  anhydride;  11,  13-dihydro-13-prolyl-
ixerin  Z;  3-p-coumaroylquinic  acid;  5-caffeoylquinic  acid;  3-feruloylquinic  acid;  4-
caffeoylquinic  acid;  caffeic  acid;  5-p-coumaroylquinic  acid;  1,  3-dicaffeoylquinic  acid;    4-
feruloylquinic  acid;  luteolin-7-O-β-D-gentiobioside;  sonchifolactone  D;  luteolin-7-O-β-D-
glucuronide; luteolin-7-O-β-D-glucoside; 3,4-dicaffeoylquinic acid; 3, 5-dicaffeoylquinic acid; 
11β-hydroxyleucodin-11-O-β-glucopyranoside;  apigenin-7-O-β-D-glucuronide;  ixerin  Z;   
apigenin-7-O-β-D-glucoside;  4,  5-dicaffeoylquinic  acid;  11β-hydroxyleucodin-11-O-β-
glucopyranoside isomer; 11β,13-dihydroixerin Z; luteolin; 11, 13-dihydro-13-prolyl-ixerin Z1;    
acacetin-7-O-β-D-rutinoside (HAO-MING et al., 2013; YING et al., 2013). 
 
Retrieval Methods 
   We logged on to PubChem Homepage (http://www.ncbi.nlm.nih.gov/pccompound) and 
searched for “Uridine”. We got the Uridine’s CID number (6029) from the site, and we linked 
back to PubChem homepage and clicked “chemical structure search” below “PubChem Tool”. 
From the display, we clicked on “CID, SMILES, INCHI” below “identity similarity”, and input 
6029 in the blank, unfold “option” menu. We chose similarity greater than 90 and other options 
were default. At last, we clicked “search” to enter next level (ZHANG et al., 2013). 
On the basis of PubChem database results, there were 1623 results. On the right side of 
webpage, we saw the item “BioActivity Experiments” under “Refine your results”. Then, we 
clicked  “Bioassays  Active  (53)”,  and  got  53  main  active  ingredients.  Next,  we  clicked 
“BioActivity Analysis” under “Action on your results”, and finished target analysis for these 53 
active  components.  The  item  of  “target”  was  the  useful  result  we  needed.  We  then  clicked 
“download”  to  download  the  contents.  In  the  downloaded  file,  data  of  “active  compounds” 
showed that results 1-5 were meaningful targets. Found with these meaningful targets was a 
corresponding “sequence GI used in assays”, and these GI number was organized for the next 
step (ZHANG et al., 2013). After it, we found  out all the corresponding  GI number  of main 
components in Ixeris sonchifolia and organized them for the next step. 
We  logged  on  to  David  homepage  (http://david.abcc.ncifcrf.gov/summary.jsp)  and 
clicked  “upload”  under  “start  analysis”.  We  input  all  the  GI  numbers,  chose  “protein  GI 78                                                                                                                 GENETIKA, Vol. 46, No.1, 75-94, 2014 
Accession” for “step 2”, chose “gene list” for “step 3”, then started search and observation of 
results. We clicked “genetic association db disease class”, for pop up in another page. Then we 
could get the Gene ID, Targets and Functions. Finally, we clicked “download file” to completely 
organize the results. Until now, we totally finished the whole search session and got the aimed 
results (ZHANG et al., 2013). 
 
RESULTS 
About the effective constituents of Ixeris sonchifolia Injection, there was no record about 
3,4-dihydroxy-caftaric acid in David Database. There was no record of caffeic anhydride; 11, 13-
dihydro-13-prolyl-ixerin  Z;  3-p-coumaroylquinic  acid;  4-caffeoylquinic  acid;  5-p-
coumaroylquinic acid; 4-feruloylquinic acid; luteolin-7-O-β-D-gentiobioside; sonchifolactone D; 
11β-hydroxyleucodin-11-O-β-glucopyranoside;  ixerin  Z;  4,  5-dicaffeoylquinic  acid;  11β-
hydroxyleucodin-11-O-β-glucopyranoside isomer; 11β, 13-dihydroixerin Z and 11, 13-dihydro-
13-prolyl-ixerin Z1 in PubChem Database. Others results of Gene ID, targets and functions of 
Ixeris sonchifolia injection are shown in Table 1. 
 
Table 1. Gene ID, gene targets and functions of Ixeris sonchifolia injection 
No.  Gene ID  Gene Targets  Functions 
1  2393947  ADAM metallopeptidase domain 10  Neurological 
2  42741659 
ATP-binding cassette, sub-family B 
(MDR/TAP), member 1 
Aging, cancer, cardiovascular, immune, 
infection, metabolic, neurological, 
normalvariation, other, 
pharmacogenomic, Psychological, renal, 
unknown, and vision 
3  67462103 
ATP-binding cassette, sub-family G 
(WHITE), member 2 
Cancer, cardiovascular, normalvariation, 
pharmacogenomic 
4  231632  B-cell CLL/lymphoma 2 
Cancer, developmental, hematological, 
immune, other 
5  2493274 
BCL2-antagonist/killer 1; BCL2-like 7 
pseudogene 1 
Cancer 
6  728945  BCL2-associated X protein  Cancer, hematological, immune 
7  4557365  Bloom syndrome, RecQ helicase-like  Cancer 
8  55977782  CD38 molecule  Immune, metabolic, unknown 
9  116241283  CREB binding protein  Neurological, other, pharmacogenomic 
10  10864009 
CTD (carboxy-terminal domain, RNA 
polymerase II, polypeptide A) small 
phosphatase 1 
Infection 
11  4503351  DNA (cytosine-5-)-methyltransferase 1  Immune 
12  125370 
FYN oncogene related to SRC, FGR, 
YES 
Cardiovascular, chemdependency, 
neurological, psychological 
13  121945198  HtrA serine peptidase 1  Neurological, vision 
14  119579178  Janus kinase 2 
Cancer, cardiovascular, developmental, 
hematological, pharmacogenomic, 
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15  124263658  Kruppel-like factor 5 (intestinal)  Metabolic 
16  118607  NAD(P)H dehydrogenase, quinone 1 
Cancer, chemdependency, 
hematological, immune, metabolic, 
neurological, normalvariation, other, 
pharmacogenomic, renal, reproduction 
17  255652944  Niemann-Pick disease, type C1  Other 
18  3063388 
Parkinson disease (autosomal recessive, 
juvenile) 2, parkin 
Infection, neurological 
19  18418623  SMAD family member 3  Cancer, infection, metabolic 
20  119579215 
SWI/SNF related, matrix associated, 
actin dependent regulator of chromatin, 
subfamily a, member 2 
Psych 
21  2358024 
T cell receptor alpha constant; T cell 
receptor alpha locus; T cell receptor 
alpha variable 20; T cell receptor delta 
locus; T cell receptor delta variable 2 
Immune 
22  20140568  TAR DNA binding protein  Psych 
23  47678753  X-box binding protein 1 
Chemdependency, Psychological, 
unknown 
24  113037  Acetylcholinesterase (Yt blood group) 
Neurological, normalvariation, other, 
Psychological, renal, unknown 
25  1709543  Acid phosphatase 1, soluble 
Cardiovascular, developmental, immune, 
infection, metabolic, other, 
psychological, reproduction 
26  231473  Adenosine A1 receptor 
Cardiovascular, pharmacogenomic, 
psychological 
27  543740  Adenosine A2a receptor 
Cardiovascular, chemdependency, 
neurological, other, pharmacogenomic, 
psychological 
28  6840802  Adenosine kinase  Immune 
29  20141702  Adenosylhomocysteinase  Cardiovascular, 
30  4501969  Adrenergic, beta-2-, receptor, surface 
Aging, cancer, cardiovascular, 
developmental, immune, infection, 
metabolic, normalvariation, other, 
pharmacogenomic, psychological, 
reproduction, unknown 
31  30582681 
Aldehyde dehydrogenase 1 family, 
member A1 
Chemdependency, pharmacogenomic 
32  113596 
Aldo-keto reductase family 1, member 
B1 (aldose reductase) 
Cardiovascular, developmental, immune, 
metabolic, neurological, other, renal, 
unknown, vision 
33  24497585 
Aldo-keto reductase family 1, member 
C4 (chlordecone reductase; 3-alpha 
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hydroxysteroid dehydrogenase, type I; 
dihydrodiol dehydrogenase 4) 
34  116734717 
Alkaline phosphatase, 
liver/bone/kidney 
Cardiovascular, immune, metabolic, 
other 
35  1351933 
Amylase, alpha 1A (salivary); amylase, 
alpha 1B (salivary); amylase, alpha 1C 
(salivary) 
Metabolic, neurological 
36 
112927, 
257380 
Amyloid beta (A4) precursor protein  Neurological, psych 
37 
124375976, 
113830 
Androgen receptor 
Aging, cancer, cardiovascular, 
developmental, immune, metabolic, 
neurological, normalvariation, other, 
psychological, reproduction 
38  4885057  Apelin receptor  Cardiovascular 
39  13399304 
Apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide-like 3G 
Infection 
40 
25987838, 
154426292 
Arachidonate 12-lipoxygenase  Cancer, cardiovascular, metabolic, psych 
41 
126396, 
1832253 
Arachidonate 15-lipoxygenase  Cardiovascular, metabolic 
42  126407  Arachidonate 5-lipoxygenase 
Cancer, cardiovascular, immune, 
neurological, pharmacogenomic 
43  4502331  Arginine vasopressin receptor 1A  Other, psych 
44  4502333  Arginine vasopressin receptor 1B  Psych 
45  267256  Arginine vasopressin receptor 2  Metabolic, renal 
46 
51095037, 
4502003 
Aryl hydrocarbon receptor 
Cancer, cardiovascular, 
developmental, metabolic, 
normalvariation, Psychological, 
reproduction, vision 
47  2702319 
Aryl hydrocarbon receptor nuclear 
translocator 
Other, reproduction 
48  171543895  Ataxin 2  Immune, neurological 
49 
728984, 
1698399 
Breast cancer 1, early onset 
Cancer, normalvariation, other, 
pharmacogenomic 
50  116353  Butyrylcholinesterase 
Cardiovascular, metabolic, 
neurological, normalvariation, other, 
pharmacogenomic, psychological 
51  62362414 
C-abl oncogene 1, receptor tyrosine 
kinase 
Cancer 
52  49037474 
Calmodulin 3 (phosphorylase 
kinase, delta); Calmodulin 2 
(phosphorylase kinase, delta); 
Calmodulin 1 (phosphorylase 
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kinase, delta) 
53  153791733  Casein kinase 1, gamma 2  Neurological 
54 
77416852, 
14790119 
Caspase 3, apoptosis-related 
cysteine peptidase 
Cancer, developmental 
55  28558771 
Caspase 9, apoptosis-related 
cysteine peptidase 
Cancer, developmental, immune, 
metabolic 
56  1705894  Chemokine (C-C motif) receptor 4  Immune 
57  37622910  Cholinergic receptor, muscarinic 1 
Chemdependency, immune, 
neurological, psychological 
58  52426748  Cholinergic receptor, muscarinic 4  Psychological 
59  7108336  Cholinergic receptor, muscarinic 5  Psychological 
60  180352  Coagulation factor XI 
Cancer, cardiovascular, 
hematological 
61 
13124873, 
13124881 
Core-binding factor, beta subunit  Cancer 
62  30219 
Corticotropin releasing hormone 
binding protein 
Psychological 
63  116051  Cyclin-dependent kinase 2  Cancer 
64  20072248 
Cyclin-dependent kinase 5, 
regulatory subunit 1 (p35) 
Developmental 
65  266423  Cyclin-dependent kinase 6  Cancer 
66 
90421313, 
89348172 
Cystic fibrosis transmembrane 
conductance regulator (ATP-
binding cassette sub-family C, 
member 7) 
Cancer, cardiovascular, 
developmental, immune, infection, 
metabolic, other, reproduction, 
unknown 
67  117139 
Cytochrome P450, family 1, 
subfamily A, polypeptide 1 
Aging, cancer, cardiovascular, 
hematological, immune, infection, 
metabolic, neurological, normal 
variation, other, pharmacogenomic, 
reproduction, unknown, vision 
68 
117144, 
73915100 
Cytochrome P450, family 1, 
subfamily A, Polypeptide 2 
Cancer, cardiovascular, chem.-
dependency, hematological, immune, 
metabolic, neurological, 
normalvariation, other, 
pharmacogenomic, Psychological, 
reproduction, unknown, vision 
69  48429256 
Cytochrome P450, family 1, 
subfamily B, polypeptide 1 
Aging, cancer, chemdependency, 
developmental, immune, metabolic, 
neurological, normalvariation, other, 
pharmacogenomic, reproduction, 
unknown, vision 
70 
119597822
, 117293 
Cytochrome P450, family 19, 
subfamily A, polypeptide 1 
Cancer, cardiovascular, 
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neurological, normalvariation, other, 
Psychological, reproduction, 
unknown 
71 
60416369, 
4503219 
Cytochrome P450, family 2, 
subfamily C, polypeptide 19 
Cancer, cardiovascular, immune, 
infection, metabolic, neurological, 
normalvariation, other, 
pharmacogenomic, Psychological, 
reproduction, unknown 
72 
13699818, 
6686268 
Cytochrome P450, family 2, 
subfamily C, polypeptide 9 
Cancer, cardiovascular, 
hematological, immune, metabolic, 
neurological, normalvariation, other, 
pharmacogenomic, Psychological, 
reproduction 
73 
84028191, 
68509921, 
40805836 
Cytochrome P450, family 2, 
subfamily D, polypeptide 6 
Aging, cancer, cardiovascular, 
chemdependency, hematological, 
immune, infection, metabolic, 
neurological, normalvariation, other, 
pharmacogenomic, Psychological, 
renal, reproduction, unknown, vision 
74 
116241312
, 13435386 
Cytochrome P450, family 3, 
subfamily A, polypeptide 4 
Cancer, cardiovascular, 
developmental, hematological, 
immune, infection, metabolic, 
neurological, normalvariation, 
pharmacogenomic, renal, 
reproduction, unknown 
75  118447  Deoxycytidine kinase 
Cancer, normalvariation, 
pharmacogenomic 
76  17391426  Dihydrolipoamide dehydrogenase  Neurological 
77  1352311  Dipeptidyl-peptidase 4  Immune 
78 
4503383, 
299681 
Dopamine receptor D1 
Cardiovascular, chemdependency, 
neurological, pharmacogenomic, 
Psychological 
79  4503385  Dopamine receptor D2 
Cancer, chemdependency, metabolic, 
neurological, normalvariation, other, 
pharmacogenomic, Psychological, 
reproduction, unknown 
80  89191863  Dopamine receptor D3 
Cancer, cardiovascular, 
chemdependency, metabolic, 
neurological, normalvariation, 
pharmacogenomic, Psychological 
81  21315078 
Endoplasmic reticulum 
aminopeptidase 1 
Cardiovascular, other 
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83  21361095 
Enhancer of zeste homolog 2 
(Drosophila) 
Cancer 
84  2811086 
Epidermal growth factor receptor 
(erythroblastic leukemia viral (v-
erb-b) oncogene homolog, avian) 
Cancer, immune, infection, 
metabolic, normalvariation, other, 
pharmacogenomic, renal, unknown 
85 
544257, 
118764400 
Estrogen receptor 1 
Cancer, cardiovascular, 
chemdependency, developmental, 
hematological, immune, infection, 
metabolic, neurological, 
normalvariation, other, 
pharmacogenomic, Psychological, 
reproduction, unknown 
86  10835013  Estrogen receptor 2 (ER beta) 
Cancer, cardiovascular, 
hematological, immune, metabolic, 
neurological, other, 
pharmacogenomic, Psychological, 
reproduction 
87  168985070 
Euchromatic histone-lysine N-
methyltransferase 2 
Cancer 
88  4758356 
Flap structure-specific 
endonuclease 1 
Neurological 
89  156630887  Fms-related tyrosine kinase 3 
Cancer, metabolic, other, 
pharmacogenomic 
90  4503779  Formyl peptide receptor 1  Immune 
91  4503895  Galactokinase 1  Metabolic, vision 
92  6016094  Galanin receptor 2  Chemdependency 
93  4503907  Galanin receptor 3  Chemdependency 
94  7705682  Geminin, DNA replication inhibitor  Cancer 
95  1724069  Glucagon-like peptide 1 receptor  Metabolic 
96  4503951  Glucokinase (hexokinase 4) 
Cardiovascular, immune, metabolic, 
other, unknown, vision 
97  119393891  Glucosidase, alpha; acid  Metabolic, other 
98  496369 
Glucosidase, beta; acid (includes 
Glucosylceramidase) 
Metabolic, neurological, other 
99  71051501  Glutaminase  Psychological 
100  31933  Glutathione S-transferase mu 1 
Aging, cancer, cardiovascular, 
chemdependency, developmental, 
hematological, immune, infection, 
metabolic, neurological, 
normalvariation, other, 
pharmacogenomic, Psychological, 
renal, reproduction, unknown, vision 
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101  4758484 
Glutathione S-transferase 
omega 1 
Cancer, cardiovascular, 
neurological, normalvariation, 
pharmacogenomic 
102  7669492 
Glyceraldehyde-3-phosphate 
dehydrogenase-like 6; 
hypothetical protein 
LOC100133042; 
glyceraldehyde-3-phosphate 
dehydrogenase 
Neurological, reproduction 
103  21361340 
Glycogen synthase kinase 3 
beta 
Cancer, chemdependency, 
metabolic, neurological, 
pharmacogenomic, 
Psychological 
104  134039205  Glyoxalase I 
Cardiovascular, immune, 
infection, other, Psychological, 
unknown 
105  19855073 
Heat shock 27kDa protein-like 
2 pseudogene; heat shock 
27kDa protein 1 
Neurological 
106  12803275 
Heat shock 70kDa protein 1A; 
heat shock 70kDa protein 1B 
Aging, cancer, cardiovascular, 
immune, infection, metabolic, 
neurological, other, 
pharmacogenomic, 
Psychological, renal, 
reproduction 
107  5729877  Heat shock 70kDa protein 8  Cancer, renal 
108  462333 
Heat shock transcription factor 
1 
Cancer 
109  4504349  Hemoglobin, beta 
Cardiovascular, hematological, 
infection, metabolic, 
normalvariation, other, unknown 
110  31077205 
Hepatocyte nuclear factor 4, 
alpha 
Immune, metabolic 
111  90903231  Huntingtin 
Neurological, other, 
Psychological, unknown 
112  544152 
Hydroxysteroid (17-beta) 
dehydrogenase 2 
Cancer, metabolic 
113  222080095  Hypocretin (orexin) receptor 1  Other 
114 
32879895, 
4504385 
Hypoxia inducible factor 1, 
alpha subunit (basic helix-
loop-helix transcription factor) 
Cancer, cardiovascular, 
hematological, metabolic, other, 
vision 
115  155969707  Insulin-degrading enzyme 
Developmental, metabolic, 
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116  59036749 
Insulin-like growth factor 2 
(somatomedin A); insulin; 
INS-IGF2 readthrough 
transcript 
Aging, cancer, cardiovascular, 
developmental, immune, 
metabolic, neurological, 
normalvariation, other, 
Psychological, reproduction, 
unknown, vision 
117  67191027 
Integrin, alpha 4 (antigen 
CD49D, alpha 4 subunit of 
VLA-4 receptor) 
Cardiovascular, immune 
118  108936015  Interleukin 8 receptor, alpha 
Cancer, immune, infection, 
other, vision 
119  21327705  Kallikrein-related peptidase 7  Immune 
120  1170955 
Macrophage migration 
inhibitory factor 
(glycosylation-inhibiting 
factor) 
Cardiovascular, immune, 
infection, metabolic, 
neurological, normalvariation, 
other, pharmacogenomic, renal 
121  116852 
Matrix metallopeptidase 1 
(interstitial collagenase) 
Aging, cancer, cardiovascular, 
developmental, immune, 
infection, metabolic, 
neurological, normalvariation, 
other, reproduction, unknown 
122  729179 
Matrix metallopeptidase 12 
(macrophage elastase) 
Cancer, cardiovascular, immune, 
other 
123  1168998 
Matrix metallopeptidase 13 
(collagenase 3) 
Cancer, cardiovascular, immune 
124  4826834 
Matrix metallopeptidase 14 
(membrane-inserted) 
Immune 
125  116856 
Matrix metallopeptidase 2 
(gelatinase A, 72kDa 
gelatinase, 72kDa type IV 
collagenase) 
Cancer, cardiovascular, 
chemdependency, immune, 
metabolic, other, reproduction 
126  116857 
Matrix metallopeptidase 3 
(stromelysin 1, progelatinase) 
Aging, cancer, cardiovascular, 
developmental, immune, 
infection, neurological, other, 
reproduction, vision 
127  269849668 
Matrix metallopeptidase 9 
(gelatinase B, 92kDa 
gelatinase, 92kDa type IV 
collagenase) 
Cancer, cardiovascular, immune, 
infection, metabolic, 
neurological, other, 
Psychological, renal, 
reproduction, vision 
128  119508433  Melanocortin 4 receptor 
Metabolic, normalvariation, 
Psychological 
129  21595776 
Methyl-CpG binding domain 
protein 2 
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130  143811423 
Methylthioadenosine 
phosphorylase 
Metabolic 
131  40807040 
Microphthalmia-associated 
transcription factor 
Metabolic, other 
132  92096784 
Microtubule-associated 
protein tau 
Developmental, neurological, 
other, Psychological, unknown 
133  18860839  Multiple endocrine neoplasia I  Cancer, metabolic, other 
134  46395496  Neuropeptide S receptor 1  Immune 
135  4505445  Neuropeptide Y receptor Y1 
Developmental, metabolic, 
normal variation 
136  4505447  Neuropeptide Y receptor Y2  Metabolic 
137  110611243 
Neurotensin receptor 1 (high 
affinity) 
Psychological 
138  115298672 
Neutrophil cytosolic factor 1; 
neutrophil cytosolic factor 1C 
pseudogene 
Immune 
139 
224028257, 
20149576 
Nuclear factor (erythroid-
derived 2)-like 2 
Other 
140 
21620132, 
34577122 
Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells 1 
Cancer, cardiovascular, immune, 
infection, neurological, 
pharmacogenomic 
141  22538455  Nuclear receptor coactivator 1  Cardiovascular 
142  32307126  Nuclear receptor coactivator 3 
Cancer, metabolic, 
normalvariation, other 
143  23503089 
Nuclear receptor subfamily 1, 
group H, member 3 
Cardiovascular, metabolic 
144 
121069, 
66528677 
Nuclear receptor subfamily 3, 
group C, member 1 
(glucocorticoid receptor) 
Cancer, cardiovascular, 
chemdependency, 
developmental, immune, 
metabolic, normalvariation, 
other, pharmacogenomic, 
Psychological, renal 
145  20070193 
Nuclear receptor subfamily 5, 
group A, member 1 
Developmental, metabolic 
146  116242691  Opioid receptor, kappa 1  Chemdependency 
147 
2851402, 
117940060 
Opioid receptor, mu 1 
Cancer, chemdependency, 
metabolic, neurological, other, 
pharmacogenomic, 
Psychological 
148  118377  Ornithine decarboxylase 1  Cancer, other, pharmacogenomic 
149  32307152  Oxytocin receptor  Psychological 
150  998701  Paired box 8  Metabolic W. JIN et al: DATEBASE, Ixeris sonchifolia , GENE TARGETS                                                                     87 
151  5453898 
Peptidylprolyl cis/trans 
isomerase, NIMA-interacting 
1 
Neurological 
152 
13432234, 
216409692, 
20336229 
Peroxisome proliferator-
activated receptor gamma 
Aging, cancer, cardiovascular, 
immune, metabolic, 
neurological, normalvariation, 
other, pharmacogenomic, 
Psychological, reproduction 
153  18266879 
Phosphatidylinositol-5-
phosphate 4-kinase, type II, 
alpha 
Psychological 
154  126302584 
Phosphoinositide-3-kinase, 
catalytic, alpha polypeptide 
Cancer, pharmacogenomic 
155  129483 
Phospholipase A2, group IIA 
(platelets, synovial fluid) 
Cancer, cardiovascular, 
metabolic, Psychological 
156  270133071 
Phospholipase A2, group VII 
(platelet-activating factor 
acetylhydrolase, plasma) 
Cardiovascular, immune, 
metabolic, Psychological 
157  223459640  Phospholipase C, gamma 1  Immune, Psychological 
158  6648082  Phosphorylase, glycogen, liver  Immune 
159  4758878 
Platelet-activating factor 
acetylhydrolase 2, 40kDa 
Cardiovascular 
160  130781 
Poly (ADP-ribose) polymerase 
1 
Aging, cancer, immune, 
metabolic, neurological, 
pharmacogenomic, renal, vision 
161  154350220 
Polymerase (DNA directed) 
iota 
Cancer 
162  7705344 
Polymerase (DNA directed) 
kappa 
Cancer 
163 
544186, 
4505931 
Polymerase (DNA directed), 
beta 
Cancer, pharmacogenomic 
164  50403732 
Polymerase (DNA directed), 
delta 1, catalytic subunit 
125kDa 
Cancer 
165  11093520 
Potassium channel, subfamily 
K, member 3 
Psychological 
166  32479527 
Potassium voltage-gated 
channel, KQT-like subfamily, 
member 1 
Cardiovascular, 
chemdependency, other 
167  4557729 
Potassium voltage-gated 
channel, subfamily H (eag-
related), member 2 
Cardiovascular, 
chemdependency, other 
168  4506113  Prion protein  Aging, cancer, metabolic, 88                                                                                                                 GENETIKA, Vol. 46, No.1, 75-94, 2014 
neurological, other, 
Psychological, reproduction 
169  215273868  Prolyl endopeptidase  Psychological 
170  31881630 
Prostaglandin E receptor 2 
(subtype EP2), 53kDa 
Cardiovascular, immune 
171  3915797 
Prostaglandin-endoperoxide 
synthase 2 (prostaglandin G/H 
synthase and cyclooxygenase) 
Cancer, cardiovascular, 
hematological, immune, 
infection, metabolic, 
neurological, normalvariation, 
other, pharmacogenomic, 
Psychological, reproduction 
172  131467 
Protein tyrosine phosphatase, 
non-receptor type 1 
Cardiovascular, metabolic 
173  116242696 
Purinergic receptor P2X, 
ligand-gated ion channel, 4 
Cardiovascular, Psychological 
174  1352692 
Purinergic receptor P2Y, G-
protein coupled, 1 
Hematological, 
pharmacogenomic, 
175  21263830 
Purinergic receptor P2Y, G-
protein coupled, 11 
Cardiovascular, 
176 
86301163, 
5032039 
Regulator of G-protein 
signaling 4 
Neurological, pharmacogenomic, 
Psychological, 
177  18677729 
Relaxin/insulin-like family 
peptide receptor 2 
Developmental 
178  132608  Ribonucleotide reductase M1  Cancer, pharmacogenomic 
179  1730070 
Ribosomal protein S6 kinase, 
90kDa, polypeptide 3 
Developmental 
180  187960042  Selectin E 
Cancer, cardiovascular, 
developmental, immune, 
infection, metabolic, 
normalvariation, renal, unknown, 
vision 
181  6274552 
Signal transducer and 
activator of transcription 1, 
91kDa 
Infection 
182  13272532 
Signal transducer and 
activator of transcription 3 
(acute-phase response factor) 
Cardiovascular, immune, 
pharmacogenomic 
183  15724400 
Signal transducer and 
activator of transcription 6, 
interleukin-4 induced 
Immune, infection, 
pharmacogenomic, renal, 
reproduction 
184  3719421 
Similar to Werner syndrome 
protein; Werner syndrome, 
RecQ helicase-like 
Cancer, cardiovascular, 
metabolic, pharmacogenomic W. JIN et al: DATEBASE, Ixeris sonchifolia , GENE TARGETS                                                                     89 
185  38258652 
Sirtuin (silent mating type 
information regulation 2 
homolog) 5 (S. cerevisiae) 
Psychological 
186  74732700 
Solute carrier family 22 
(organic anion/urate 
transporter), member 12 
Metabolic, renal 
187  11141885 
Solute carrier family 5 
(choline transporter), member 
7 
Cardiovascular, neurological 
188  17433306 
Solute carrier family 5 (low 
affinity glucose cotransporter), 
member 4 
Psychological 
189  10937869 
Survival of motor neuron 1, 
telomeric; survival of motor 
neuron 2, centromeric 
Neurological, other 
190  586067 
Synuclein, alpha (non A4 
component of amyloid 
precursor) 
Chemdependency, neurological, 
other, Psychological 
191  6226780 
Telomerase reverse 
transcriptase 
Cancer, cardiovascular, 
hematological 
192  120660324  Thrombopoietin  Cardiovascular, hematological 
193  189491771 
Thyroid hormone receptor, 
beta (erythroblastic leukemia 
viral (v-erb-a) oncogene 
homolog 2, avian) 
Immune, metabolic, other, 
Psychological 
194  38016895 
Thyroid stimulating hormone 
receptor 
Cancer, cardiovascular, immune, 
metabolic, other, vision 
195  4507681 
Thyrotropin-releasing 
hormone receptor 
Cardiovascular 
196  13959709 
Topoisomerase (DNA) II 
alpha 170kDa 
Cancer, pharmacogenomic 
197  116242818 
Transforming growth factor, 
beta receptor II (70/80kDa) 
Cancer, cardiovascular, 
developmental, metabolic, other, 
Psychological, renal 
198  4507593 
Tumor necrosis factor (ligand) 
superfamily, member 10 
Immune, infection 
199  224494019 
Tumor necrosis factor receptor 
superfamily, member 10b 
Immune, normal variation 
200 
120407068, 
269849759, 
23491729 
Tumor protein p53 
Aging, cancer, cardiovascular, 
immune, infection, metabolic, 
neurological, normalvariation, 
other, pharmacogenomic, 
Psychological, vision 90                                                                                                                 GENETIKA, Vol. 46, No.1, 75-94, 2014 
201  4507949 
Tyrosine 3-
monooxygenase/tryptophan 5-
monooxygenase activation 
protein, beta polypeptide 
Immune 
202  119533 
V-erb-b2 erythroblastic 
leukemia viral oncogene 
homolog 2, 
neuro/glioblastoma derived 
oncogene homolog (avian) 
Cancer, metabolic, 
pharmacogenomic 
203  111305821  Valosin-containing protein  Psychological 
204  63054845 
Vitamin D (1,25- 
dihydroxyvitamin D3) 
receptor 
Aging, cancer, cardiovascular, 
hematological, immune, 
infection, metabolic, 
neurological, normalvariation, 
other, pharmacogenomic, renal, 
reproduction 
 
 
DISCUSSION 
According  to  detailed  results  of  each  ingredient,  the  frequency  of  “aging”  function, 
“hematological”,  “renal”,  “vision”,  “chemdependency”,  “unknown”,  “infection”, 
“developmental”, “normalvariation”, “reproduction”, “pharmacogenomic”, “psych”, “immune”, 
“neurological”, “metabolic”, “other”, “cardiovascular”, and “cancer” is 49, 59, 65, 80, 99, 101, 
104, 108, 138, 140, 178, 208, 251, 252, 257, 276, 282, and 361, respectively. 
Research  conducted  by  YAOCHUN  et  al.  (2009)  suggested  that  flavonoids,  particularly 
luteolin,  in  IIxeris  sonchifolia  contribute  to  the  neuroprotective  effects,  which  made  the 
compounds from these herb reasonable candidates for treatment of cerebral ischemia-reperfusion 
diseases. In  our  research,  we  had found  that  there  were 56  genes  in  the total  154  genes  of 
“luteolin” having the “Neurological” function, and at the same time, there were 16 genes with 
the function of “Hematological” improvement. 
Ixeris sonchifolia had definite curative effects on ischemic optic neuropathy, which could 
improve the blood-supply balance and optical microcirculation by changing blood rheological 
characteristics  and  hemodynamics  with  no  absolute  adverse  reaction,  so  there  were  greatly 
significant points on promoting the early recovery and improving the quality of life in patients 
(HELI, 2013). In our research, we had found that there were 80 genes in the total 3008 genes 
having the “Vision” function, and at the same time, there were 59 genes in total with the function 
of “Hematological” improvement. The effects of genes on “Metabolic” function may be able to 
accelerate the blood cell’s regeneration. 
Reports showed that Ixeris sonchifolia Injection could contribute to remove the free radical, 
restrain the  platelet aggregation and enhance the activity  of plasmin to  protect the ischemia 
injury (YOUSEF, et al., 2004; JINNA et al., 2006). In our research, we had found that there were 59 
genes in the total 3008 genes having the “Hematological” function, and at the same time, there 
were 257  genes  in  total with the  function  of “Metabolic” improvement,  which  may  offer  a 
reasonable evidence for the previous researches. W. JIN et al: DATEBASE, Ixeris sonchifolia , GENE TARGETS                                                                     91 
In Li et al’s research, intravenous drip infusion of Ixeris sonchifolia injection was given to 
72 patients with atherosclerosis once daily. Levels of prostaglandin I2 (PGI2), endothelin (ET) 
and thromboxane A2 (TXA2) were tested from fasting venous blood samples (3 mL) before and 
after treatment for 1 week.. Compared with the previous levels before treatment, significantly 
Ixeris sonchifolia injection decreased TXA 2 and ET respectively, but obviously increased PGI2 
(P<0.01).  So  Ixeris  sonchifolia  injection  could  improve  and  adjust  the  abnormal  secretory 
function of vascular endothelial cells, so vascular endothelial cells could be considered as one of 
the targets of Ixeris sonchifolia effect (ZHAO-LIANG et al., 2013). In our research, there were 257 
genes  with  the  “Metabolic”  function  and  282  genes  with  the  “Cardiovascular”  function. 
Especially the genes ID 31881630 and 3915797 had significant effects on prostaglandin G/H 
synthase and cyclooxygenase. 
Interleukin-6  (IL-6)  was  a  kind  of  acute  reactive  protein,  produced  by  T  lymphocytes, 
mononuclear macrophages, fibroblasts, endothelial cells and muscle cells, which was named as 
pro-inflammatory cytokine with tumor necrosis factor and interleukin-1, and it could mediate 
inflammatory  and  stress  reaction.  C-reactive  protein  (CRP) was  the  firstly  discovered  acute 
response protein in body, which was generally believed as a very sensitive inflammatory tissue 
damage marker. IL - 6 and CRP increased and participated in the occurrence and development of 
atherosclerosis, playing a very important role. Ixeris sonchifolia injection had protective effect 
on brain tissue by lowering plasma CRP and IL-6 levels,and could improve the total effective 
rate (QINGLING, 2011). In another experiment, it could reduce the IL-8 and TNF-α levels to 
improve the  COPD  Assessment  Test  in  COPD  patients (LIFANG  and  MEIJIAN,  2012).  In  our 
research, there were 104 genes with the “Infection” function and 251 genes with the “Immune” 
function. Especially the genes ID 15724400 and 108936015 had significant effects on IL-4 and 
IL-8 receptor respectively. 
Ixeris sonchifolia could accelerate recovery speed of urinary protein, serum albumin, blood 
fat, blood coagulation function in primary nephrotic syndrome patients, and had great clinical 
significance  in  helping  treat  the  PNS  and  improve  the  prognosis  of  nephrotic  syndrome 
(XIAOJUAN et al., 2013). In our research, there were 65 genes showing the effects on “Renal” 
function. 
Report showed that the quantity of B16 melanoma living cells and survival rate reduced 
significantly, the expression level of anti-apoptotic protein Bcl-2 downregulated, the expression 
level of pro-apoptotic  protein Bax  upregulated, the quantity  of apoptotic  bodies and  evident 
karyopyknosis rose and the quantity of mitochondria reduced with dose-dependent manner of 
IIxeris sonchifolia injection. So IIxeris sonchifolia inhibits malignant melanoma cell growth and 
enhanced apoptosis cells related to protein Bcl-2/Bax with a linear relationship (WANG et al., 
2013).  In  our  research,  the  highest  frequency,  361,  of  “Cancer”  function  might  lay  a  solid 
foundation for the above research. 
   
CONCLUSION 
Ixeris  sonchifolia  Hance  has  effects  on  appendicitis,  headache,  menstruation,  blood 
circulation,  blood  stasis,  pain,  fibrinolytic  enzymes,  thrombus  formation,  coronary  artery, 
myocardial  infarct  size,  PGI2,  ET,  TXA2,  TNF,  α-IL-6,  and  IL-8.  In  this  research,  we  had 
detected the gene IDs, gene targets, and their functions about Ixeris sonchifolia Injection based 
on the method of information integration among various databases. 16 kinds of definite functions 92                                                                                                                 GENETIKA, Vol. 46, No.1, 75-94, 2014 
had been found, 9 of which had laid a solid foundation for previous reports of Ixeris sonchifolia 
Injection’s effects, and according to the frequency of genes (n > 200), the effects were focused 
on the psychological, immune, neurological, metabolic, cardiovascular, and cancer functions. At 
the same time, according to our results, the Ixeris sonchifolia injection may have influences on 
aging, chemdependency, developmental, normal-variation, reproduction, pharmacogenomic and 
psychologic functions, which should be verified in the future experiments. 
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Izvod 
Ixeris  sonchifolia  Hance,  normalna  perenialna  trava  ima  efekta  na  upalu  slepog  creva, 
glavobolju, menstruaciju, cirkulaciju krvi, zastoj krvi, bolove, fibrinolitičke enzyme, formiranje 
tromba, koronarne arterije, veličinu miocardialnog infarkta, PGI2, ET, TXA2, TNF-,αIL-6 ,IL-8, 
etc.  Merđutim,  nije  utvđeno  potpuno  pokrivanje  molekularne  osnove  i  target  gena  Ixeris 
sonchifolia injectiranja. PubChem Database i DAVID Database  su korišćene zajedno u detekciji 
gena IDs , ciljnih gena I njihove funkcije. Konačno je nađeno 3008 gena, 16 vrsta konačnih 
funkcija od kojih je za potvrđen efekat fokusiran na fiziološke, immune, neurološke, metaboličke 
I kancerogene funkcije. Ixeris sonchifolia  je imao širok efekat na različite simptome koji su 
utvrđeni  u  ranijim  eksperimentima  i  potvrđene  rezultatima  istraživanja.  Uticaj  na  starenje, 
zavisnost  na  hemikalije,  razvojne  funkcije,  normalno  variranje,  reprodukciju,  farmakogene  I 
psihološke funkcije treba da budu potvrđene u budućim eksperimentima.   
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